Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas
Author:
Funder
Associazione Bianca Garavaglia
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference209 articles.
1. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project;Stiller;Eur. J. Cancer,2013
2. Sarcoma treatment in the era of molecular medicine;Grünewald;EMBO Mol. Med.,2020
3. Molecular mechanisms underpinning sarcomas and implications for current and future therapy;Damerell;Signal Transduct. Target Ther.,2021
4. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies;Knott;Cancer Metastasis Rev.,2019
5. Biology and therapy of dominant fusion oncoproteins involving transcription factor and chromatin regulators in sarcomas;Perry;Ann. Rev. Cancer Biol.,2019
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas;Disease Models & Mechanisms;2024-06-01
2. Unlocking epigenetics for precision treatment of Ewing's sarcoma;CHINESE J CANCER RES;2024
3. BML-281 promotes neuronal differentiation by modulating Wnt/Ca2+ and Wnt/PCP signaling pathway;Molecular and Cellular Biochemistry;2023-09-28
4. Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors;Biochemical Pharmacology;2023-09
5. A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma;Frontiers in Oncology;2023-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3